(Q52206236)

27 April 2018

title

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs. (English)

1 reference

27 April 2018

author name string

G R Dawson

1

1 reference

27 April 2018

N M Rupniak

2

1 reference

27 April 2018

S D Iversen

3

1 reference

27 April 2018

R Curnow

4

1 reference

27 April 2018

S Tye

5

1 reference

27 April 2018

K J Stanhope

6

1 reference

27 April 2018

M D Tricklebank

7

1 reference

27 April 2018

publication date

1 September 1995

1 reference

27 April 2018

published in

Psychopharmacology

1 reference

27 April 2018

volume

121

1 reference

27 April 2018

issue

1

1 reference

27 April 2018

page(s)

109-117

1 reference

27 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02245597

exact match

0 references

cites work

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245597

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245597

The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245597

Anxiolytic effects of CCK-B antagonists

21 January 2018

1 reference

12 December 2020

Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

1 reference

12 December 2020

High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group

1 reference

12 December 2020

An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.

1 reference

12 December 2020

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

1 reference

12 December 2020

Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.

1 reference

12 December 2020

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

12 December 2020

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

12 December 2020

Conditioned suppression as a monitor of fear of the CS in the course of avoidance training.

1 reference

12 December 2020

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

1 reference

12 December 2020

Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?

1 reference

12 December 2020

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

1 reference

12 December 2020

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.

1 reference

12 December 2020

Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding

1 reference

12 December 2020

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245597

1 reference

27 April 2018

1 reference

27 April 2018